Cytek Biosciences, Inc. CTKB 深 沪
已收盘 02-06 16:00:00 美东时间
4.475
-0.025
-0.56%
华盛通- 最 高6.04
- 今 开4.53
- 成交量 263.30万股
- 最 低 4.35
- 昨 收 4.50
- 总市值 59.97万
- 52周最高 6.04
- 市盈率 静 --
- 换手率 1964.91%
- 52周最低 0.00
- 委 比 38.99%
- 总股本 0.00亿
- 历史最高 6.04
- 量 比 3.46
- 振 幅 37.56%
- 历史最低 0.00
- 每 手 1
- 风险率 0.81%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多昆仑资本荣获「年度最佳CVC科技投资机构」等九项荣誉
（来源：昆仑万维（维权）） 昆仑资本由昆仑万维创始人周亚辉先生于2015年创立，专注于科技创新型企业投资，当前已在量子计算、可控核聚变、脑机接口、生物基因...
2025-09-03 18:54
Cytek® Biosciences Is Setting the New Standard for Full Spectrum Flow Cytometry with the New Cytek Aurora™ Evo Flow Cytometer
Cytek Biosciences unveiled the Cytek Aurora™ Evo system, a next-generation full spectrum flow cytometer offering improved sample throughput, automation capabilities, and enhanced detection of small particles. Building on the trusted performance of the Cytek Aurora system, the Aurora Evo empowers researchers with high-speed workflows and consistent data quality to accelerate discoveries in cell analysis.
2025-05-29 21:00
Cytek Biosciences to participate at the Goldman Sachs 46th Annual Global Healthcare Conference
Cytek Biosciences will participate in the Goldman Sachs 46th Global Healthcare Conference on June 11 in Miami Beach, with management set to join a fireside chat at 11:40 a.m. PT / 2:40 p.m. ET. The company, headquartered in Fremont, California, specializes in advanced cell analysis solutions and offers products for research and clinical use in specific regions.
2025-05-28 20:05
